ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1347 • ACR Convergence 2022

    Poor Health-Related Quality of Life in Patients with Lupus Nephritis

    Cristina Arriens1, Janice Ma2, Konrad Pisarczyk2, Richard Leff3, Kiruthi Palaniswamy4 and Li Long4, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Maple Health Group, LLC, New York, NY, 3Kezar Life Sciences, South San Francisco, CA, 4Kezar Life Sciences, Inc., South San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is one of the most serious manifestations of systemic lupus erythematosus (SLE) associated with considerable morbidity that has a devastating impact…
  • Abstract Number: 1373 • ACR Convergence 2022

    Increased Patient Contact May Mitigate Flares Among jSLE Patients

    Jessica Fennell, Deanna Jannat-Khah, DrPH, MSPH and karen onel, Hospital for Special Surgery, New York, NY

    Background/Purpose: Optimizing jSLE management is crucial to prevent flares as the damage sustained during flares contributes to lifelong morbidity and mortality. The onset of the…
  • Abstract Number: 1358 • ACR Convergence 2022

    Adherence to Early DMARD Strategies in Newly Diagnosed RA Patients Seen in Routine Care: Results from the Canadian Early Arthritis Cohort Study

    Yuxuan Jiang1, orit schieir2, Marie-France Valois2, Susan Bartlett3, Louis Bessette4, Gilles Boire5, Glen Hazlewood6, Carol Hitchon7, Edward Keystone8, Diane Tin9, Carter Thorne10, Vivian Bykerk11, Janet Pope12 and Canadian Early Arthritis Cohort (CATCH) Investigators13, 1Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada, 2McGill University, Montréal, QC, Canada, 3McGill University, Montreal, QC, Canada, 4Centre de l'Ostoporose et de Rhumatologie de Québec, Québec, QC, Canada, 5Universite de Sherbrooke, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 9The Arthritis Program Research Group, Newmarket, ON, Canada, 10Southlake Regional Health Centre, Newmarket, ON, Canada, 11Hospital for Special Surgery, New York, NY, 12University of Western Ontario, London, ON, Canada, 13The Canadian Early Arthritis Cohort (CATCH), Bowmanville, ON, Canada

    Background/Purpose: Early diagnosis coupled with early intensive treatment strategies have led to marked improvements in rheumatoid arthritis (RA) patient outcomes. Despite improved access to numerous…
  • Abstract Number: 1372 • ACR Convergence 2022

    Telemedicine Use in the Assessment of Juvenile Dermatomyositis and Polymyositis: A Survey of Caregivers and Patients

    Stacey Tarvin1, Y. Ingrid Goh2, Nicole Taylor3, Bianca Lang4, Marietta De Guzman5, Julie Fuller6, Kristin Houghton7, Susan Kim8, Vanessa Carbone9, Kathryn Cook10, Tanya Slater9, Angela Robinson11, Liza McCann12, Charalampia Papadopoulou13, Clarissa Pilkington14, Phoebe Rushe15 and Peter Blier16, 1Riley Hospital for Children at Indiana University Health, Indianapolis, IN, 2Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute, Toronto, ON, Canada, 3University of Indianapolis, Indianapolis, IN, 4Dalhousie University - Halifax, Halifax, NS, Canada, 5Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 6UT Southwestern, Frisco, TX, 7University of British Columbia - Vancouver, Vancouver, BC, Canada, 8UCSF Benioff Children's Hospital, San Francisco, CA, 9The Hospital for Sick Children, Toronto, ON, Canada, 10Akron Children's Hospital, Copley, OH, 11Cleveland Clinic, Cleveland, OH, 12Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 13UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Section Head Infection, Immunology, and Rheumatology, London, United Kingdom, 14Great Ormond Street Hospital, London, United Kingdom, 15Royal Liverpool University Hospital, Liverpool, United Kingdom, 16Retired, Amherst, MA

    Background/Purpose: Care of patients with juvenile myositis (JM) involves complex assessments performed by highly trained specialists. Restrictions surrounding the COVID-19 pandemic resulted in many patients…
  • Abstract Number: 1371 • ACR Convergence 2022

    Juvenile Onset SLE in India-Data from a Multi-institutional Inception (INSPIRE) Cohort of Systemic Lupus Erythematosus

    Amita Aggarwal1, Liza Rajasekhar2, Parasar Ghosh3, Ashish J Mathew4, Chengappa Kavadichanda5, Vineetha Shobha6, Ranjan Gupta7, Saumya Ranjan Tripathy8, Manish Rathi9, Avinash Jain10 and Able Lawrence1, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Nizam's Institute of Medical Sciences, Madhapur, India, 3Govt of West Bengal, Kolkata, India, Kolkata, West Bengal, India, 4Rigshospitalet, Copenhagen, Denmark, 5JIPMER, Pondicherry, Puducherry, India, 6St. John’s Medical College Hospital, Bangalore, India, 7All India Institute of Medical Sciences, New Delhi, India, 8SCB medical college, Cuttack, India, 9PGIMER Chandigarh, Chandigarh, India, 10SMS Medical College, Lucknow, India

    Background/Purpose: Most Lupus cohorts across the globe have poor representation of patients from South Asia who are ethnically different. We explored the clinical features and…
  • Abstract Number: 1367 • ACR Convergence 2022

    Patient and Physician Reported Outcomes of Juvenile Systemic Sclerosis Patients Significantly Improve over 12 Months Observation Period in the Juvenile Systemic Scleroderma Inception Cohort

    Ivan Foeldvari1, Jens Klotsche2, Ozgur Kasapcopur3, Amra Adrovic4, Kathryn Torok5, Maria Teresa Terreri6, Brian Feldman7, Jordi Anton8, Maria Katsicas9, Valda Stanevica10, FLAVIO SZTAJNBOK11, Simone Appenzeller12, Tadey Avcin13, Mikhail Kostik14, Edoardo Marrani15, Walter Alberto Sifuentes-Giraldo16, Sindu Johnson17, Raju Khubchandani18, Dana Nemcova19, Maria José Santos20, Cristina Battagliotti21, Lillemor Berntson22, Blanca Bica23, Jürgen Brunner23, Rolando Cimaz24, Despina Eleftheriou25, Liora Harel26, Gerd Horneff27, Mahesh Janarthanan28, Tilmann Kallinich29, Kirsten Minden30, Anjali Patwardhan31, Dieneke Schonenberg-Meinema32, Vanessa Smith33 and Nicola Helmus34, 1Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3Istanbul University-Cerrahpaşa, Cerrahpaşa Medical School, Istanbul, Turkey, 4Cerrahpaşa Medical School, Istanbul University, Istanbul, Turkey, 5Pediatric Rheumatology, Children's Hospital of UPMC, Pittsburgh, PA, 6Universidad Federal São Paulo, São Paulo, Brazil, 7Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 8Pediatric Rheumatology, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain, 9Hospital Garrahan, Buenos Aires, Argentina, 10Children's Clinical University Hospital, Zemgales priekšpilseta, Riga, Latvia, 11UFRJ/UERJ, São Paulo, Brazil, 12Unicamp, Campinas, São Paulo, Brazil, 13University Children's Hospital University Medical Center Ljubljana, Ljubljana, Slovenia, 14Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 15University of Florence, Firenze, Italy, 16Hospital Universitario Ramon y Cajal, Madrid, Spain, 17University of Toronto, Toronto, ON, Canada, 18SRCC Children's Hospital, Mumbai, India, 19Charles University, Prague, Czech Republic, 20Hospital Garcia de Orta, Almada, Charneca da Caparica, Portugal, 21Hospital de Niños Dr Orlando Alassia, Santa Fe, Argentina, 22Dept. of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden, 23UNIVERSIDADE FEDERAL DO RIO DE JANEIRO, Rio de Janeiro, Brazil, 24University of Milano, Milano, Italy, 25Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 26Schneider Children's Medical center, Tel Aviv University, Nettnja, Israel, 27Pediatrics, Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany, 28SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH, Chennai, India, 29Charité - Universitätsmedizin Berlin, Nuremberg, Germany, 30Charité Universitätsmedizin Berlin, Berlin, Germany, 31University of Missouri, Columbia, MO, 32Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 33Department of Rheumatology, Ghent University Hospital – Department of Internal Medicine, Ghent University, Belgium – Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Gent, Belgium, 34Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is an orphan disease with a prevalence of 3 in 1 000 000 children. The Juvenile Systemic Scleroderma Inception cohort…
  • Abstract Number: 1318 • ACR Convergence 2022

    Low-Dose Prednisolone (≤5 Mg/d) Is Not Associated with Deleterious Effects on Bone Mineral Density: Baseline Findings in a Cohort of Rheumatic Disease Patients with Prior Glucocorticoid Exposure

    Edgar Wiebe1, Dörte Huscher2, Desirée Schaumburg1, Andriko Palmowski1, Sandra Hermann1, Thomas Buttgereit3, Robert Biesen4, Gerd Burmester5, Yannick Palmowski6, Maarten Boers7, John Stone8, Christian Dejaco9 and Frank Buttgereit10, 1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 2Institute of Biometry and Clinical Epidemiology, and Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 3Department of Dermatology, Venerology and Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 4Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 5Charité University Medicine Berlin, Berlin, Germany, 6Spine Department, Center for Musculoskeletal Surgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 7Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 8Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 9Department of Rheumatology, Hospital of Brunico (SABES-ASDAA), Brunico, Italy, and Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 10Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin / DRFZ Berlin, Berlin, Germany

    Background/Purpose: Inflammatory rheumatic and musculoskeletal diseases (iRMD) are associated with increased systemic bone loss that is mediated by chronic inflammation, treatment with glucocorticoids (GC), and…
  • Abstract Number: 1350 • ACR Convergence 2022

    A Prospective Study on Pain Associated with Injection of Needles: PAIN Study

    Chay Bae1, Eugenia Chen1 and Maida Wong2, 1Rheumatology, University of California, Irvine School of Medicine, Irvine, CA, 2Rheumatology, VA Long Beach Healthcare System, Long Beach, CA

    Background/Purpose: Joint pain is a common issue amongst patients. In the appropriate clinical setting, joint injections or aspirations may benefit the patient. Pain, however, is…
  • Abstract Number: 1363 • ACR Convergence 2022

    Impact of SARS-CoV-2 on the Clinical Presentation of Juvenile Idiopathic Inflammatory Myopathies

    Jessica Perfetto1, Donna Yoo2, Carolina Tamashiro3, Megan Perron4, Natalia Vasquez Canizares5 and Dawn Wahezi6, 1The Children's Hospital at Montefiore, Division of Rheumatology, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3The Children's Hospital at Montefiore, Department of Pediatrics, Bronx, NY, 4Children's Hospital Colorado, Division of Rheumatology, Aurora, CO, 5Children's Hospital at Montefiore/ Albert Einstein College of Medicine, New York, NY, 6Children's Hospital at Montefiore, Bronx, NY

    Background/Purpose: Viruses can trigger juvenile idiopathic inflammatory myopathies (JIIM), including juvenile dermatomyositis (JDM), juvenile polymyositis (JPM), and overlap myositis. There is growing evidence that infection…
  • Abstract Number: 1265 • ACR Convergence 2022

    External Validation of a Giant Cell Arteritis Probability Score (GCAPS) to Risk Stratify GCA Referrals: Experience from a United Kingdom Fast Track Clinic

    Edward Appleby1 and Qasim Akram2, 1Stockport NHS Foundation Trust, Altrincham, United Kingdom, 2NHS- Stockport, Manchester, United Kingdom

    Background/Purpose: Giant Cell Arteritis (GCA) is the most common large vessel vasculitis which can result in irreversible blindness if not diagnosed and treated promptly. We…
  • Abstract Number: 1327 • ACR Convergence 2022

    Immune Cell Subsets and Risk of Incident Hip Fracture in Older Adults: The Cardiovascular Health Study

    Rachel Elam1, Petra Buzkova2, Joseph Delaney3, Howard Fink4, Joshua Barzilay5, Laura Carbone1, Rick Saha1, John Robbins6, Kenneth Mukamal7, Rodrigo Valderrabano8, Bruce Psaty2, Russell Tracy9, Nels Olson9, Sally Huber10, Margaret Doyle9, Alan Landay11 and Jane Cauley12, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3University of Manitoba, Winnipeg, MB, Canada, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA, 6UC Davis, Davis, CA, 7Beth Israel Deaconess Medical Center, Boston, MA, 8Brigham and Women's Hospital, Boston, MA, 9University of Vermont, Burlington, VT, 10University of Vermont, Burlingon, VT, 11Rush University Medical Center, Chicago, IL, 12University of Pittsburgh, PIttsburgh, PA

    Background/Purpose: Cell-mediated immunity may play a role in osteoporosis development. Fracture is the major consequence of osteoporosis. Thus, cell-mediated immunity may impact fracture risk. We…
  • Abstract Number: 1359 • ACR Convergence 2022

    Usability and Acceptability of a Digital Behavioral Therapy for the Management of Fibromyalgia

    Nelson Mitchell1, Yifei Dai2, Michael Rosenbluth3, Allison Kraus1, Maggie Avila1, Aabha Morey1, Michael Gendreau4, Nicolette Vega1, Zunera Ghalib1 and Brian Keefe5, 1Swing Therapeutics, San Francisco, 2Swing Therapeutics, Gainesville, FL, 3Swing Therapeutics, San Francisco, CA, 4GENDREAU CONSULTING, LLC, Poway, CA, 5Swing Therapeutics, New York, NY

    Background/Purpose: Cognitive behavioral therapy (CBT) is considered a gold-standard treatment with demonstrated level 1A evidence for management of fibromyalgia (FM). Acceptance and Commitment Therapy (ACT),…
  • Abstract Number: 1254 • ACR Convergence 2022

    Ultra High‐Frequency Ultrasound of Labial Salivary Glands in Primary Sjögren’s Syndrome: A Promising Tool to Identify Lymphoproliferative Lesions in Unusual Sites

    Giovanni Fulvio1, Rossana Izzetti2, Francesco Ferro3, Gianmaria Governato4, Gaetano La Rocca5, Silvia Fonzetti6, Inmaculada Concepción Navarro García7, Marta Mosca8, Valentina Donati9 and Chiara Baldini1, 1University of Pisa, Pisa, Pisa, Italy, 2Unit of Dentistry and Oral Surgery, Pisa, Toscana, Italy, 3Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 4Azienda Ospedaliera Universitaria Pisana, Pisa, Pisa, Italy, 5University of Pisa, Rheumatology Unit, Palermo, Palermo, Italy, 6Azienda Ospedaliera Universitaria Pisana, Pisa, Italy, 7Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 8Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 9Pathology Unit, University of Pisa, Pisa, Italy

    Background/Purpose: Major salivary gland (MSG) ultrasound (US) is a useful tool in Sjögren's syndrome (SS) diagnostic work-up. Interestingly, in a recent case series, specific US…
  • Abstract Number: 1370 • ACR Convergence 2022

    Abatacept in the Treatment of Refractory Juvenile Dermatomyositis

    Gulnara Mamyrova1, William Nguyen2, Hassan Awal1, Derek Jones1, Alison Ehrlich3, Kathleen Brindle4, Shahriar Haji-Momenian4, Robert Sheets5, Adeline Y. Chin6, Shajia Lu7, Massimo Gadina7, Hanna Kim8, Olcay Y. Jones9, Lisa G Rider10 and Rodolfo V Curiel1, 1Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, 2Division of Rheumatology, Department of Medicine, George Washington University, School of Medicine and Health Sciences, Washington, DC, 3Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC, 4Department of Radiology, George Washington University School of Medicine and Health Sciences, Washington, DC, 5Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of California San Diego, Rady Children's Hospital, San Diego, CA, 6Juvenile Myositis Therapeutic and Translation Studies Unit, PTRB, NIAMS, NIH, Bethesda, MD, 7Translational Immunology Section, NIAMS, NIH, Bethesda, MD, 8Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences; Juvenile Myositis Therapeutic and Translation Studies Unit, PTRB, NIAMS, NIH, Bethesda, MD, 9Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences; Pediatric Rheumatology, Walter Reed National Military Medical Center, Bethesda, MD, 10Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Bethesda, MD

    Background/Purpose: This open-label 24-week study was conducted to evaluate the safety and efficacy of abatacept in patients with refractory juvenile dermatomyositis (JDM).Methods: Ten patients of…
  • Abstract Number: 1338 • ACR Convergence 2022

    Patients’ Perspectives and Experiences of Medication Use in Osteoporosis – a Qualitative Systematic Review and Thematic Synthesis

    Sagarika Dey1, Gloria Spratt2, Muguet Koobasi3, Carol Vleeskens4, Carlos El-Haddad5 and Ayano Kelly6, 1School of Clinical Medicine, South Western Sydney Campus, University of New South Wales, Parramatta, New South Wales, Australia, 2Physiotherapy Department and Rheumatology Department, Liverpool Hospital; Zone34 Sports Physiotherapy, Liverpool, Australia, 3Knowledge Centre for Health Ghent, Ghent University, Ghent, Belgium, 4Sydney Partnership for Health Medical Research and Enterprise Consumer Community Council, Liverpool, Australia, 5Rheumatology Department, Liverpool Hospital, Liverpool, Australia, 6South Western Sydney Campus, UNSW Medicine & Health, Braddon, Australia

    Background/Purpose: Suboptimal adherence to anti-osteoporotic medications presents a growing social and economic concern. Yet, it is unclear what patients' perspectives and experiences are regarding medication…
  • « Previous Page
  • 1
  • …
  • 374
  • 375
  • 376
  • 377
  • 378
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology